Suche

Free radicals promote the development of liver cancer ... Golob-Schwarzl, Thomas Mohr, Doris Kaltenecker, Jerome Bourgeais, Jamile Paier-Pourani, Katrin Friedbichler, Doris Schneller, Michaela Schlederer, Eva Zebedin-Brandl, Luigi M. Terracciano, Xiaonan Han, Lukas Kenner, Kay-Uwe Wagner, Wolfgang Mikulits, Andrey V. Kozlov, Markus H. Heim, Fabrice Gouilleux... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-in-october-2016/free-radicals-promote-the-development-of-liver-cancer/

New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/university/

New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/medicine-science/

PSMA ligand PET/MRI provides accurate diagnosis of prostate cancer ... Mitterhauser, Theresa Balber, Neydher Berroteran-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, Markus Hartenbach: PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact. Clin... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-im-september-2018/psma-ligand-petmri-provides-accurate-diagnosis-of-prostate-cancer/medicine-science/

PSMA ligand PET/MRI provides accurate diagnosis of prostate cancer ... Mitterhauser, Theresa Balber, Neydher Berroteran-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, Markus Hartenbach: PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact. Clin... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-im-september-2018/psma-ligand-petmri-provides-accurate-diagnosis-of-prostate-cancer/people-of-the-meduni-vienna/

New methods take us closer to targeted, personalised cancer treatment ... Hall of MedUni Vienna from 28 - 30 September. This specialist symposium brings together top international researchers from many disciplines and representatives from industry. Thomas Beyer, Gerda Egger, Marcus Hacker, Lukas Kenner, Oliver Langer, Markus Mitterhauser, Shahrokh Shariat, Wolfgang Wadsak... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-september-2016/new-methods-take-us-closer-to-targeted-personalised-cancer-treatment/

PSMA ligand PET/MRI provides accurate diagnosis of prostate cancer ... Mitterhauser, Theresa Balber, Neydher Berroteran-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, Markus Hartenbach: PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact. Clin... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-im-september-2018/psma-ligand-petmri-provides-accurate-diagnosis-of-prostate-cancer/

Bürgermeisterfonds der Stadt Wien fördert zahlreiche Forschungsprojekte der MedUni Wien ... Kastrationsresistenten Krebs der ProstataProjekt-Leiter: Lukas KennerKlinisches Institut für Pathologie Janus kinase directed mesenchymal tissue response to inflammation in arthritisProjekt-Leiter: Hans-Peter KienerUniversitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie Computergestützte... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2017/news-im-maerz-2017/buergermeisterfonds-der-stadt-wien-foerdert-zahlreiche-forschungsprojekte-der-meduni-wien/

Bürgermeisterfonds der Stadt Wien fördert zahlreiche Forschungsprojekte der MedUni Wien ... Kastrationsresistenten Krebs der ProstataProjekt-Leiter: Lukas KennerKlinisches Institut für Pathologie Janus kinase directed mesenchymal tissue response to inflammation in arthritisProjekt-Leiter: Hans-Peter KienerUniversitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie Computergestützte... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2017/news-im-maerz-2017/buergermeisterfonds-der-stadt-wien-foerdert-zahlreiche-forschungsprojekte-der-meduni-wien/medizin-wissenschaft/

City of Vienna Bürgermeisterfonds finances numerous MedUni Vienna research projects ... biomarkers in castration-resistant prostate cancer Project leader: Lukas Kenner Department of Pathology Janus kinase directed mesenchymal tissue response to inflammation in arthritis Project leader: Hans-Peter Kiener Department of Medicine III, Division of Rheumatology Computerised layer control in 2... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-in-march-2017/city-of-vienna-buergermeisterfonds-finances-numerous-meduni-vienna-research-projects/

Personen